Detrimental role of the airway mucin Muc5ac during ventilator-induced lung injury

Mucosal Immunology

Volumn 6, Issue 4, 2013, Pages 762-775

  Koeppen, M ^a,b   McNamee, E N ^a   Brodsky, K S ^a   Aherne, C M ^a   Faigle, M ^c   Downey, G P ^a,d   Colgan, S P ^a   Evans, C M ^a   Schwartz, D A ^a   Eltzschig, H K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCIN 5AC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; BRONCHUS MUCOSA; CELL MIGRATION; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG LAVAGE; LUNG PARENCHYMA; MICROARRAY ANALYSIS; MOUSE; MUCUS; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN INDUCTION; VENTILATOR INDUCED LUNG INJURY;

EID: 84873998418     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.114     Document Type: Article

References (79)

1. Ware, L. B. & Matthay, M. A. The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334-1349 (2000).
2. Rubenfeld, G.D.etal. Incidence and outcomesofacute lung injury. N. Engl. J. Med. 353, 1685-1693 (2005).
3. Belperio, J. A. et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 110, 1703-1716 (2002).
4. Reutershan, J., Cagnina, R.E., Chang, D., Linden, J. & Ley, K. Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J. Immunol. 179, 1254-1263 (2007).
5. Reutershan, J. et al. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J. Clin. Invest. 116, 695-702 (2006).
6. Martin, T. R. Neutrophils and lung injury: getting it right. J. Clin. Invest. 110, 1603-1605 (2002).
7. Abraham, E., Carmody, A., Shenkar, R. & Arcaroli, J. Neutrophils as early immunologic effectors in hemorrhage-or endotoxemia-induced acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L1137-1145 (2000).
8. Azoulay, E. et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit. Care Med. 30, 781-786 (2002).
9. Baughman, R. P., Gunther, K. L., Rashkin, M. C., Keeton, D. A. & Pattishall, E. N. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am. J. Respir. Crit. Care Med. 154, 76-81 (1996).
10. Fahy, J. V. & Dickey, B. F. Airway mucus function and dysfunction. N. Engl. J. Med. 363, 2233-2247 (2010).
11. Thornton, D. J., Rousseau, K. & McGuckin, M.A. Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol. 70, 459-486 (2008).
12. Rose, M. C. & Voynow, J. A. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 86, 245-278 (2006).
13. Chen, Y., Zhao, Y. H., Di, Y. P. & Wu, R. Characterization of human mucin 5B gene expression in airway epithelium and the genomic clone of the amino-terminal and 5′-flanking region. Am. J. Respir. Cell Mol. Biol. 25, 542-553 (2001).
14. Young, H. W. et al. Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5′ elements. Am. J. Respir. Cell Mol. Biol. 37, 273-290 (2007).
15. Evans, C. M. et al. Mucin is produced by clara cells in the proximal airways of antigen-challenged mice. Am. J. Respir. Cell Mol. Biol. 31, 382-394 (2004).
16. Hasnain, S. Z. et al. Muc5ac: a critical component mediating the rejection of enteric nematodes. J. Exp. Med. 208, 893-900 (2011).
17. Galaup, A. et al. Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation 125, 140-9 (2012).
18. Knowles, M. R. & Boucher, R. C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109, 571-577 (2002).
19. Seibold, M. A. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 364, 1503-1512 (2011).
20. Eckle, T., Grenz, A., Laucher, S. & Eltzschig, H. K. A2B adenosine receptor signaling attenuates acute lung injuryby enhancing alveolar fluid clearance in mice. J. Clin. Invest. 118, 3301-3315 (2008).
21. Schingnitz, U. et al. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J. Immunol. 184, 5271-5279 (2010).
22. Reutershan, J., Vollmer, I., Stark, S., Wagner, R., Ngamsri, K. C. & Eltzschig, H. K. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 23, 473-482 (2009).
23. Fujisawa, T., Velichko, S., Thai, P., Hung, L. Y., Huang, F. & Wu, R. Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm. J. Immunol. 183, 6236-6243 (2009).
24. He, B. J. et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat. Med. 17, 1610-1618 (2011).
25. Boucher, R. C. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu. Rev. Med. 58, 157-170 (2007).
26. Boucher, R. C. Idiopathic pulmonary fibrosis-a sticky business. N. Engl. J. Med. 364, 1560-1561 (2011).
27. Evans, C. M., Kim, K., Tuvim, M. J. & Dickey, B. F. Mucus hypersecretion in asthma: causes and effects. Curr. Opin. Pulm. Med. 15, 4-11 (2009).
28. Eckle, T., Fullbier, L., Grenz, A. & Eltzschig, H. K. Usefulness of pressure-controlled ventilation at high inspiratory pressures to induce acute lung injury in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L718-724 (2008).
29. Eckle, T. et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J. Immunol. 178, 8127-8137 (2007).
30. Koeppen, M., Eckle, T. & Eltzschig, H. K. Pressure controlled ventilation to induce acute lung injury in mice. J. Vis. Exp., pii: 25252011).
31. Li, D., Gallup, M., Fan, N., Szymkowski, D. E. & Basbaum, C. B. Cloning of the amino-terminal and 5′-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts. J. Biol. Chem. 273, 6812-6820 (1998).
32. Waelchli, R. et al. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK. Bioorg. Med. Chem. Lett. 16, 108-112 (2006).
33. Rosenberger, P. et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10, 195-202 (2009).
34. Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R. & Boucher, R. C. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N. Engl. J. Med. 354, 241-250 (2006).
35. Casalino-Matsuda, S. M., Monzon, M. E., Day, A. J. & Forteza, R. M. Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium. Am. J. Respir. Cell Mol. Biol. 40, 277-285 (2009).
36. Sciuto, A. M., Strickland, P. T., Kennedy, T. P. & Gurtner, G. H. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am. J. Respir. Crit. Care Med. 151 (3 Part 1), 768-772 (1995).
37. Inci, I., Zhai, W., Arni, S., Hillinger, S., Vogt, P. & Weder, W. N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation. Ann. Thorac. Surg. 84, 240-246 (2007). discussion 246.
38. Liu, D. D., Kao, S. J. & Chen, H. I. N-acetylcysteine attenuates acute lung injury induced by fat embolism. Crit. Care Med. 36, 565-571 (2008).
39. Bernard, G. R. et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 112, 164-172 (1997).
40. Suter, P. M., Domenighetti, G., Schaller, M. D., Laverriere, M. C., Ritz, R. & Perret, C. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 105, 190-194 (1994).
41. Kreda, S. M. et al. Coordinated release of nucleotides and mucin from human airway epithelial Calu-3 cells. J. Physiol. 584 (Part 1), 245-259 (2007).
42. Korcok, J., Raimundo, L. N., Du, X., Sims, S. M. & Dixon, S. J. P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. J. Biol. Chem. 280, 16909-16915 (2005).
43. Kreda, S.M. etal. Receptor-promoted exocytosisofairway epithelial mucin granules containing a spectrum of adenine nucleotides. J. Physiol. 588 (Part 12), 2255-2267 (2010).
44. Eckle, T., Koeppen, M. & Eltzschig, H. K. Role of extracellular adenosine in acute lung injury. Physiology (Bethesda) 24, 298-306 (2009).
45. Eltzschig, H. K. Adenosine: an old drug newly discovered. Anesthesiology 111, 904-915 (2009).
46. Ahmad, S. et al. Lung epithelial cells release ATP during ozone exposure: signaling for cell survival. Free Radic. Biol. Med. 39, 213-226 (2005).
47. Button, B., Picher, M. & Boucher, R. C. Differential effects of cyclic and constant stresson ATP release and mucociliary transportby human airway epithelia. J. Physiol. 580 (Part. 2), 577-592 (2007).
48. Faigle, M., Seessle, J., Zug, S., El Kasmi, K. C. & Eltzschig, H. K. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS ONE 3, e2801(2008).
49. Eltzschig, H. K. et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ. Res. 99, 1100-1108 (2006).
50. Eltzschig, H.K., Macmanus, C. F. & Colgan, S. P. NeutrophilsasSources of Extracellular Nucleotides: Functional Consequences at the Vascular Interface. Trends Cardiovasc. Med. 18, 103-107 (2008).
51. Weissmuller, T. et al. PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J. Clin. Invest. 118, 3682-3692 (2008).
52. Young, H. W., Sun, C. X., Evans, C. M., Dickey, B. F. & Blackburn, M. R. A3 adenosine receptor signaling contributes to airway mucin secretion after allergen challenge. Am. J. Respir. Cell Mol. Biol. 35, 549-558 (2006).
53. Mohsenin, A., Mi, T., Xia, Y., Kellems, R. E., Chen, J. F. & Blackburn, M. R. Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deami-nase-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L753-761 (2007).
54. Cicko, S. et al. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J. Immunol. 185, 688-697 (2010).
55. Matsuyama, H. et al. Acute lung inflammation and ventilator-induced lung injury caused by ATP via the P2Y receptors: an experimental study. Respir. Res. 9, 792008).
56. Idzko, M. et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13, 913-919 (2007).
57. Elliott, M. R. et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461, 282-286 (2009).
58. Liedtke, C. M., Wang, X. & Smallwood, N. D. Role for protein phosphatase 2Ainthe regulationofCalu-3 epithelialNa+-K +-2Cl-, type1co-transport function. J. Biol. Chem. 280, 25491-25498 (2005).
59. Haeberle, H. A. et al. Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS ONE 3, e33522008).
60. Hauber, H.P., Goldmann, T., Vollmer, E., Wollenberg, B. & Zabel, P. Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa. Am. J. Respir. Cell Mol. Biol. 37, 606-616 (2007).
61. Kreda, S. M.etal. Receptor-promoted exocytosisofairway epithelial mucin granules containing a spectrum of adenine nucleotides. J. Physiol. 588 (Pt 12), 2255-67 (2010).
62. Fischer, B. M. & Voynow, J. A. Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am. J. Respir. Cell Mol. Biol. 26, 447-452 (2002).
63. Paine, R. 3rd et al. A randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor for patients with acute lung injury. Crit. Care Med. 40, 90-7 (2012).
64. Bernard, G. R. et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med.149 (3Part 1), 818-824 (1994).
65. Seibold, M.A.etal.The concentration of MUC5AC is higher in the air space of idiopathic pulmonary fibrosis (IPF) subjects and is associated with a disease susceptibility variant (Ala497Val) in MUC5AC. Am. J. Respir. Crit. Care Med. 181, A24932012).
66. Synnestvedt, K. et al. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993-1002 (2002).
67. Eltzschig, H. K. et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleo-tidases and adenosine A2B receptors. J. Exp. Med. 198, 783-796 (2003).
68. Eckle, T., Kohler, D., Lehmann, R., El Kasmi, K. C. & Eltzschig, H. K. Hypoxia-Inducible Factor-1 Is Central to Cardioprotection: A New Paradigm for Ischemic Preconditioning. Circulation 118, 166-175 (2008).
69. Eckle, T. et al. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115, 1581-1590 (2007).
70. Grenz, A. et al. The Reno-Vascular A2B Adenosine Receptor Protects the Kidney from Ischemia. PLoS Med. 5, e1372008).
71. Kohler, D. et al. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116, 1784-1794 (2007).
72. Shekels, L. L., Lyftogt, C., Kieliszewski, M., Filie, J. D., Kozak, C. A. & Ho, S. B. Mouse gastric mucin: cloning and chromosomal localization. Biochem. J. 311 (Part 3), 775-785 (1995).
73. Eltzschig, H. K. et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 202, 1493-1505 (2005).
74. Thompson, L. F. et al. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200, 1395-1405 (2004).
75. Koeppen, M., Eckle, T. & Eltzschig, H. K. Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo. PLoS One 4, e67842009).
76. Koeppen, M., Eckle, T. & Eltzschig, H. K. Pressure controlled ventilation to induce acute lung injury in mice. J. Vis. Exp. 2011).
77. Koeppen, M. et al. Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury. Anesthesiology 116, 1245-1257 (2012).
78. Cronstein, B. N., Daguma, L., Nichols, D., Hutchison, A. J. & Williams, M. The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J. Clin. Invest. 85, 1150-1157 (1990).
79. Reutershan, J. & Ley, K. Bench-to-bedside review: acute respiratory distress syndrome-how neutrophils migrate into the lung. Crit. Care 8, 453-461 (2004).